4.3 Article

Membrane-targeting AM-0016 kills mycobacterial persisters and shows low propensity for resistance development

期刊

FUTURE MICROBIOLOGY
卷 11, 期 5, 页码 643-650

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/fmb-2015-0015

关键词

drug resistance; drug tolerance; tuberculosis

资金

  1. Singapore Ministry of Health's National Medical Research Council under its Translational Clinical Research Flagship grant [NMRC/TCR/011-NUHS/2014]
  2. Singapore Ministry of Health's National Medical Research Council under its Centre grant 'MINE'/Research Core number [4 (NMRC/CG/013/2013), SHF/FG538P/2013-SingHealth Foundation]
  3. Singapore Programme of Research Investigating New Approaches to Treatment of Tuberculosis (SPRINT-TB) [NMRC/TCR/R1018]
  4. Yong Loo Lin School of Medicine

向作者/读者索取更多资源

Aim: To test the hypothesis that targeting the cytoplasmic membrane may be an effective way to kill persister mycobacteria and delay the emergence of resistance. Methods: In vitro activity of AM-0016, a novel xanthone-based antibacterial, was assessed against growing and persister tubercle bacilli. Resistance mutation frequencies were determined. Biochemical membrane and electron microscopic analyses were carried out. Results: AM-0016 rapidly sterilized growing tubercle bacillus cultures and displayed strong bactericidal activity against persister bacteria. Spontaneous resistance mutation frequency was lower than 10(-8). Exposure to AM-0016 resulted in rapid collapse of the membrane potential. Imaging revealed deformation of the cell envelope. Conclusion: Targeting the cytoplasmic membrane may be an attractive approach to eliminate persister mycobacteria and slow down the emergence of genetic drug resistance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据